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Lipoxygenase products mediate the attachment of rat macrophages to
glomeruli in vitro. Because there is an accumulation of macrophages in
the Bowman's space during human and experimental glomerulonephri-
tis, we have studied the binding of 3H-uridine labeled macrophages to
isolated glomeruli. Binding was related to the glomerular protein and
macrophage concentrations, temperature, time of incubation, and was a
saturable process. Macrophage adherence depended on glomerular
lipoxygenase activity but not on glomerular cyclooxygenase activity
since preincubation of glomeruli with nordihydroguaiaretic acid
(NDGA) inhibited this phenomenon whereas preincubation with indo-
methacin was ineffective. Glomeruli interacted with macrophages in
converting arachidonic acid (C20:4) to prostaglandins (PG) since pro-
ductions of 6 keto-PGF1,, TXB2, and PGD2 by glomeruli and macro-
phages incubated in combination were much greater than the sums of
their respective productions by glomeruli and macrophages incubated
separately. Macrophages were the source of the supplementary synthe-
sis of PG which was abolished when these cells were pretreated with
aspirin. Stimulation of macrophages by glomeruli was blunted by
pretreatment of glomeruli with NDGA. Production of PG and of
12-HETE by macrophages was stimulated by a lipid extract of glomeruli
containing the oxygenated metabolites of C20:4. Direct addition of
l2-HPETE also stimulated macrophage functions. These data suggest
that macrophage attachment to glomeruli and macrophage stimulation
in the presence of glomeruli depend on glomerular lipoxygenase
activity.
Les produits de Ia lipoxygenase sont des médiateurs de I'adhésion des
macrophages de rat aux glomerules in vitro. Au cours des
glomérulonéphrites expérimentales et humaines; des macrophages
s'accumulent dans l'espace de Bowman, c'est pourquoi, nous avons
étudid in vitro la liaison de macrophages marques par Ia 3H-uridine a
des glomerules isolés. La liaison depend des concentrations de
protéines glomerulaire et macrophagique, du temps d'incubation et de
Ia temperature et apparait comme un phénoméne saturable. L'activité
lipoxygenasique et non cyclooxygdnasique glomérulaire intervient dans
le mCcanisme d'adhésion puisque Ia préincubation des glomérules avec
l'acide nordihydroguaiardtique (NDGA) empéche le phénomène, alors
que Ia préincubation avec l'indométacine est sans effet. Les glomérules
modifient la conversion par les macrophages de l'acide arachidonique
(C20:4) en prostaglandines (PG); en effet les productions de 6 ceto-
PGF1,,, TXB2, et PGD2 par l'association glomerules-macrophages sont
trés supérieures aux sommes des syntheses observées avec les
glomérules et les macrophages incubés sdparément. Ce sont les mac-
rophages qui sont l'origine de Ia synthese accrue des PG, puisque leur
traitement préalable par l'aspirine annule cette augmentation. La stimu-
lation des macrophages par les glomerules est atténuée lorsque les
glomerules sont préalablement traités par le NDGA. La production de
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PG et 12-HETE par les macrophages est aussi stimulde par un extrait
lipidique glomdrulaire qui contient les mdtabolites oxygènds du C20:4.
Enfin, l'addition directe de 12-HPETE stimule le mdtabolisme des
macrophages. Ces résultats suggérent que la liaison des macrophages
aux glomdrules ainsi que la stimulation des macrophages en presence
des glomérules dependent de l'activité lipoxygénasique glomérulaire.
Monocyte-macrophage cells play an important role in inflam-
mation and particularly in several forms of glomerulonephritis.
Normally present as less than 0.1 per tuft [1], macrophages
participate in endocapillary proliferation, mesangial expansion
[2] and, depending on the degree of immune response, in
crescent formation [3] during experimental nephrotoxic serum
nephritis [4—6] and glomerulonephritis of serum sickness [7, 8].
Moreover, proliferation of macrophages in Bowman's space
may be responsible for the crescentic formation in these gb-
merulonephritis [9]. A close temporal relationship has been
observed between macrophage accumulation and proteinuria
[101; the results obtained by monocyte depletion [10] or by
treatment with macrophage antiserum [11] suggested that mac-
rophages play a role in experimental immune injury to the
glomerulus. In these models, the factors responsible for
macrophage accumulation in diseased glomeruli remain un-
known. The mechanisms could be an immune adherence via Fc
receptors on macrophage [2], a chemotaxis involving the com-
plement [12], fibrin deposition [5], or products derived from
collagen breakdown [13]. In this regard, the glomerulus itself
would be only a passive supporting structure. Now it is well
known that cyclooxygenase and lipoxygenase products of ara-
chidonic acid (C20:4) contribute also significantly to the inflam-
matory process.
We and others have demonstrated production of various
prostaglandins (PG) and lipoxygenase products, predominantly
12- and 15-hydroxyeicosatetraenoic acids (HETE) by isolated
glomeruli [14—16]. Lipoxygenase products are implicated in the
stimulated migration of macrophages [17]. PGs also may play a
dual role: on the one hand they stimulate some macrophage
activities [18]; on the other hand anti-inflammatory properties
may be attributed to PGE2 and PGI2 via stimulation of cyclic
AMP generation leading to a reduction of various metabolic and
functional activities of leukocytes [19]. Thus, various metabo-
lites of C20:4 potentially present in the glomerulus could
influence the relationship between glomeruli and macrophages,
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either to enhance or to limit the inflammatory process. It is the
reason why, in the present study, we examined with a new in
vitro technique: (1) whether or not the metabolites of C20:4
from glomerular origin could modulate the adhesion of macro-
phages to normal glomeruli in the absence of any supplemen-
tary factor such as complement, immunoglobulins, fibnn or
leukocytes; (2) whether or not the interaction of glomeruli and
resting macrophages could influence the conversion of C20:4 to
cyclooxygenase and lipoxygenase products. Our results demon-
strate that glomerular lipoxygenase products both enhance
adhesion of macrophages to glomeruli and stimulate prostaglan-
din synthesis by macrophages.
Methods
Preparation of isolated glomeruli
According to a technique previously described [161, renal
glomeruli were isolated from Sprague-Dawley rats weighing 150
to 200 g. Under pentobarbital anesthesia (5 mg/l00 g body wt
i.p.), the kidneys were perfused with 50 ml heparinized saline
(NaCI 0.16 M) until they were blanched and then removed. The
cortex was dissected and minced to a paste-like consistency.
The homogenate was suspended in buffer A (20 m Tris-HC1
buffer, pH 7.4, containing 5 m glucose, 135 mi,ei NaC1, 10 mM
KCI, and 10 mM NaCH3COO) and passed successively through
a 106 LM stainless steel sieve which excluded the tubules and a
75 M stainless sieve which retained the glomeruli. The
glomeruli were resuspended and centrifuged twice at x l2Og for
90 sec. Each individual preparation was checked for purity
under light microscopy. Glomeruli were free of Bowman's
capsule and virtually no afferent or efferent arterioles could be
detected. Tubular fragments were always less than 2% of the
glomeruli.
Preparation of unlabeled and labeled macrophages
Resident macrophages were collected by peritoneal lavage
from Sprague-Dawley rats according to the method of Bonney
et al [20]. Under ether anesthesia, rats were injected intraperi-
toneally with 25 ml of Hank's balanced salt solution, pH 7.3,
containing penicillin (100 UIml), streptomycin (50 g/ml), and
heparin (20 U/mI). Three minutes later, the peritoneal fluid was
drained by gravity and gentle pressure applied to the abdomen;
it was stored at 4°C. This procedure was repeated twice.
Peritoneal cell suspensions were centrifuged for 10 mm at
x450g and the pellet was resuspended in the same medium to a
concentration of l0 cells/mi. More than 80% of the cells
obtained positively stained for nonspecific esterase [211.
In some experiments, the macrophages were labeled by
incubation for 2 hr at 37°C with 10 tCi of 5,6 3H uridine (51
Ci/mmole; The Radiochemical Centre, Amersham, United
Kingdom) per l0 cells in 1 ml of Hank's balanced salt solution.
Macrophages were maintained under continuous agitation dur-
ing the incubation period. After labeling, the cells were washed
three times and resuspended in Hank's solution at a final
concentration of 4 x 106 cells/mI. 3H uridine radioactivity was
0.0436 cpm/cell. The cell viability was always checked by
trypan blue with more than 85% of cells excluding the dye.
Attachment of macrophages to glomeruli
By morphological studies. Unlabeled macrophages with
glomeruli were incubated for 30 mm at 37°C in a final volume of
0.2 ml buffer A containing 1 mrvt CaCl2 and stopped by the
addition of 10 ml of cold buffer. In two experiments the ratio of
glomerular protein over macrophage protein was 2.17 and 3.30,
respectively. This suspension was then poured on a 50 m
stainless steel sieve which excluded free macrophages. The
glomeruli recovered on the upper side of the sieve were fixed by
immersion in 2% glutaraldehyde in 0.1 M cacodylate buffer, pH
7.4, for 1 hr at room temperature, washed overnight in 0.2 M
cacodylate buffer, postfixed in 2% aqueous osmium tetroxide
for 1 hr at room temperature, and finally dehydrated in graded
ethanol solutions and embedded in Epon. Thin sections (50 to
100 nm) were cut and stained with uranyl acetate and lead
citrate, and examined with an electron microscope (80 kV,
Philips EM-400).
By radioisotope studies. Isolated glomeruli were incubated
with labeled macrophages for 5 to 60 mm at 37°C in a shaking
water bath (80 strokes/mm) in 0.2 ml of buffer A containing 1
mM CaCl. The ratio of glomerular protein over macrophage
protein was 2.97 0.3 (range, 1.1 to 5.6) for 15 experiments. In
some experiments, glomeruli were pretreated for 30 mm at 37°C
with indomethacin (Merck Sharp & Dohme, Montreal, Quebec,
Canada), a blocker of the cyclooxygenase pathway, at I to 100
M or various blockers of the lipoxygenase pathway,
nordihydroguaiaretic acid (NDGA, Sigma Chemical Company,
St. Louis, Missouri, USA) at 1 to 100 tM, eicosatetraynoic acid
(ETYA, Roche Laboratories, Nutley, New Jersey, USA) at 100
p. and l-phenyl-3-pyrazolidone (Phenidone, Sigma Chemical
Company) at 100 LM. These inhibitors were then eliminated by
two successive washings of the glomeruli with 10 ml of buffer A
and glomeruli were added to macrophages. When incubation
ended, bound and unbound labeled macrophages were sepa-
rated by filtration (Nylon filters, 60 jtm, Züricher Beuteltuch
Fabrik AG, Ruschlikon, Switzerland), and the filter was washed
three times with 5 ml of 0.16 M ice-cold sodium chloride. After
drying, 3H radioactivity present on the filter was counted in 6
ml Picofluor TM30 (Packard Instrument Co. Inc., Downers
Grove, Illinois, USA) by a standard liquid scintillation tech-
nique with 60% efficiency. The results were expressed as counts
per minute per milligram of glomerular protein. Glomerular
protein concentration was determined according to Lowry et al
[221.
Determination of C20:4 metabolites. The formation of C20:4
metabolites was determined in separate experiments in which
isolated glomeruli and unlabeled macrophages were incubated
singly or in combination for 30 mm at 37°C. The ratio glomeru-
lar protein over macrophage protein was 3.10 0.2 (range, 1.8
to 4.7) for 14 experiments. The standard incubation contained 1
ml of buffer A, 50 nM 3H1 C20:4 (100 Ci/mmole, The Radio-
chemical Centre, Amersham, United Kingdom) and 5 mM
CaCI2. The reaction was stopped by precipitation with 2 ml of
cold methanol, Extraction of PGs and HETEs was performed
as described previously [141. The purification steps before high
performance liquid chromatography (HPLC) were the follow-
ing: the dried extracts were separated into two fractions by
silicic acid column chromatography with a modiftcation of the
method of Dray, Charbonnel, and Maclouf [23]. Fraction I
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containing C20:4 and HETEs was eluted with 10 ml of
benzene:ethylacetate (60:40; v/v). HETEs were then separated
from C20:4 on a Silicar CC4 column as described previously
[141. Fraction II containing the cyclooxygenase products was
eluted with 10 ml of benzene:ethylacetate:methanol (60:40:20;
v/v). The HETE fractions were submitted to HPLC on a Varian
model 5000 chromatograph with a micropack Si 10 column (4
mm I.D. x 30 cm) and eluted with hexane:ethanol:acetic acid
(993:6:1; v/v). In this system, HHT coeluted with 8-HETE. To
separate these two products, the following system was used:
reverse-phase column (Varian CH 10, 4 mm ID. X 30 cm);
elution with methanol:H20:acetic acid (72.5:27.5:0.01; v/v),
flow rate 1.2 mi/mm. In this system, HHT eluted at 14 mm and
8-HETE at 28 mm. PUs contained in fraction II were resolved
by HPLC using a micropack CH 10 (reverse-phase) column (4
mm ID. x 30cm). They were eluted at a flow rate of 1.8 ml/min
with H20:acetonitrile:benzene:acetic acid (790:230:2:1; v/v).
PUs were also measured in duplicate and at least at two
different dilutions by radioimmunoassay (RIA) according to
Dray et al [241 for 6 keto-PGF1,, and according to Sors et al [25]
for TXB2. Antibodies for 6 keto-PGF1, PGD2, and TXB2 were
kindly donated by Drs. Michael Dunn (Cleveland, Ohio, USA),
Fernand Dray, and Antonin Hornych (Paris, France), respec-
tively. Specificities of the two first antibodies have been previ-
ously reported in detail [26, 27]. Conditions of incubation and
separation of free and bound radioactivities for PGD2 RIA were
identical to those used for 6 keto-PGF1a. Anti-PGD2 antibody
crossreacted less than 0.1% with 6 keto-PGF1 and PGE2.
Crossreactivity with TXB2 was 1.2%. Concentration of PGD2
required to displace 50% of the specific tracer was 230 pg/mi.
3H1 6 keto-PGF1, 3H TXB2 and 3H PGD2 were purchased
from the Radiochemical Centre.
A lipid extract containing the C20:4 metabolites synthesized
by glomeruli was prepared. Isolated glomeruli (3 mg glomerular
protein) were incubated in 500 d of buffer A containing 5mrvi
CaCl2 for 30 mm at 37°C. After methanol-ether extraction, the
residue obtained was purified by chromatography on a Silicar
CC4 column. The fraction which contained the oxygenated
metabolites of C20:4, mainly PGs and 12-HETE, but not C20:4
itself, was dried under nitrogen and resuspended in 1 ml of
buffer A-ethanol (990:10; v/v). Aliquots of 100, 250, and 300 1.d
corresponding to 300, 750 and 900 g of glomerular protein,
respectively, were added to the incubation medium of macro-
phages (0.56 mg macrophage protein) containing 50 nrvi
C20:4. Conversion of 3H C20:4 into 6 keto-PGF1a, TXB2, and
12 + 15 HETE was measured by radiometric HPLC. The
control value was obtained by adding buffer A-ethanol without
lipid extract to the macrophage suspension.
12-HPETE was prepared from C20:4 by incubation with a
human platelet lysate according to Maclouf et al [28]. Macro-
phages were incubated during 30 mm at 37°C in the presence of
50 nM 3H C20:4 with or without 10 nM 12-HPETE. 3H 6
keto-PGF1, resulting from the conversion of 3H C20:4 was
measured after HPLC purification as an index of macrophage
stimulation by 12-HPETE.
Statistical analysis
The experimental results obtained after glomeruli and mac-
rophages were incubated in combination were compared, using
Student's t test for paired values, with the theoretical sum of the
Fig. 1. Transmission electron micrograph of a preparation of glomeruli
incubated with macrophages for 30 mm at 37°C. Note the endothelial
cells (EN) lining the capillary lumen, the glomerular basement mem-
brane (GBM), and the epithelial cells (EP) which are partially de-
stroyed. Macrophages (MC) are attached to the denuded glomerular
basement membrane. (Magnification x 15,000)
results obtained after glomeruii and macrophages were incu-
bated separately. The variance of the theoretical sum was
calculated as the sum of the variance of its two components.
The effect of i2-HPETE on the production of 6 keto-PGF1a by
several preparations of macrophages was estimated using the
two-way (preparation-treatment) analysis of variance.
Results
Macrophage attachment to glomeruli
By morphological studies. The attachment of macrophages to
glomeruli was observed after a 30-mm incubation. Macrophages
were seen in contact with partially damaged epithelial cells and
denuded glomerular basement membrane. These attached mac-
rophages contained many lysosomes and displayed surface
microvilli (Fig. 1).
By radioisotope studies. Adhesion of macrophages to isolated
glomeruli varied as a function of time and macrophage concen-
tration. The amount of bound 3H macrophages to glomeruli
increased progressively with time, reached a plateau after 40
mm of incubation, and was stable up to 60 mm (Fig. 2C). With
400,000 macrophages (approximately 100 sg protein) and 0.25
mg of glomerular protein, maximum binding corresponded to a
mean attachment of 2.3 macrophages per glomerulus. When
binding at the equilibrium was expressed as a function of the
number of macrophages, saturation was seen at a concentration
of 13 x 106 cells per mg glomerular protein (Fig. 2A). Under
these conditions, a mean of 17.2 macrophages was bound per
glomerulus. Macrophage binding at 30 mm was related linearly
to the amount of glomerular protein used per assay (from 50 to
450 rg per tube, Fig. 2B). Macrophage binding could therefore
be expressed as counts per minute per milligram of glomerular
protein. The binding process was also temperature-dependent.
Binding increased from 4 to 10°C, was stable between 10 and
37°C, and markedly decreased from 37 to 45°C (Fig. 2D),
Macrophage binding was reduced to less than 5% of control
Fig. 2. Binding of labeled macrophages to isolated glomeruli. Panel A
shows the amount of labeled macrophages bound per milligram of
glomerular protein as a function of the number of macrophages present
in the incubation medium. Panel B shows the number of labeled
macrophages bound as a function of glomerular protein present in the
incubation medium. Panel C shows the time-course of the binding of
labeled macrophages to isolated glomeruli. Panel D shows the binding
of labeled macrophages to isolated glomeruli as a function of the
incubation temperature. Results represent means SEM of three
experiments.
when glomeruli had been boiled for 10 mm prior to incubation
with macrophages.
Effect of glomerular PGs and HETEs on the attachment of
labeled macrophages to glomeruli. Glomeruli preincubated for
30 mm at 37°C with increasing concentrations (1 to 100 LM) of
indomethacin, an inhibitor of cyclooxygenase activity, signifi-
cantly reduced the synthesis of POE2 during a 30-mm incuba-
tion that followed (Fig. 3A). The degree of inhibition reached
82.5% after pretreatment of the glomeruli by 100 /LM of indo-
methacin (Fig. 3A). Indomethacin pretreatment caused no
inhibition of macrophage binding to glomeruli (Fig. 3A). Prein-
cubation of glomeruli for 30 mm at 37°C with increasing
concentrations (1 to 100 ELM) of NDGA, an inhibitor of
lipoxygenase activity, markedly reduced 12-HETE production
by the glomeruli during a 30-mm incubation that followed (Fig.
3B). In contrast to the results obtained with indomethacin,
pretreatment of glomeruli with NDGA decreased macrophage
adhesion (Fig. 3B). Inhibitions of 12-HETE production by
glomeruli and of macrophage binding to glomeruli were dose
dependent, with both parameters decreasing in parallel except
at the highest doses of NDGA (Fig. 3B.) Maximal inhibitions at
iO M NDGA were 66.7% for 12-HETE production and 53%
for macrophage binding. The pretreatment of glomeruli by two
other inhibitors of lipoxygenase, ETYA and phenidone, used at
iO M also inhibited macrophage binding by 45.9 and 36.7%,
respectively.
Interactions of macrophages and glomeruli in the metabolism
of C20:4
Conversion of 3HI C20:4 to PGs and HETEs by glomeruli and
macrophages incubated separately. As shown in Figure 4,
resting rat peritoneal macrophages converted exogenous 3H1
C20:4 into two main products identified by HPLC as 12-HETE
for the lipoxygenase pathway and 6 keto-PGF1 for the cyclo-
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Fig. 3. Binding of labeled macrophages to rat glomeruli (closed circles)
and PG synthesis (open circles) during 30-mm incubations. Glomeruli
had been preincubated for 30 mm with increasing concentrations of
indomethacin (upper part). The binding of labeled macrophages to rat
glomeruli (closed circles) and 13H1 12-HETE synthesis (open circles)
during 30-mm incubations are shown in the presence of 50 nM 13H1
arachidonic acid. Glomeruli had been preincubated for 30 mm with
increasing concentrations of nordihydroguaiaretic acid (NDGA) (lower
part), Binding studies and determinations of PGs or HETEs were
performed in duplicate tubes. Preincubated glomeruli were washed
before final incubation. (For details refer to Methods). The results
represent means SCM of six experiments except for 3HH12 HETE
synthesis studies (two experiments).
oxygenase pathway. Isolated glomeruli incubated under the
same conditions produced essentially 12-HETE. Only small
amounts of 3H1-labeled PGs were produced. A peak indicated
as x1 eluted between 6 keto-PGF1a and TXB2 and remained
unidentified. We previously observed this peak after glomeruli
were incubated with I'4C AA [161.
Conversion of3HI C20:4 to PGs and HETES by glomeruli and
macrophages incubated in combination. When macrophages
were incubated in combination with glomeruli, there was a
significant stimulation (P < 0.01) of the conversion of C20:4
to PGs. Figure 5 shows the amounts of I3H radioactivity
(cpm/tube) corresponding to the peaks of the main PGs pro-
B
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Fig. 4. Radiochromato grams after high performance liquid chromatog-
raphy separation of the products of 13H1 arachidonic acid conversion
into PGs (left) and HETEs (right) by glomeruli (lower part) and
macrophages (upper part). The retention times of authentic standards
are indicated by arrows. Glomeruli and macrophages were incubated
separately for 30 mm at 37°C in the presence of 50 nM I3H C20:4.
duced, 6 keto-PGF1a, TXB2, and PGD2 by glomeruli and
macrophages incubated separately or in combination. The
incubation of only glomeruli resulted in negligible conversion of
13H1 C20:4 into PGs. Macrophages alone produced some I3HI 6
keto-PGF1 and little I3HI TXB2 or 13H1 PGD2. When, however,
macrophages and glomeruli were incubated in combination,
greater amounts of I3HI PGs were produced than by either
macrophages alone or glomeruli alone or the sum of the two.
Stimulation was particularly marked for PGD2 (x 40), but was
also clear-cut for 6 keto-PGF1 (x 2.6) and for TXB2 (x 9.9).
In contrast to the results for PGs, production of PHI 12-
HETE by macrophages and glomeruli incubated in combination
(27,174 4,143 cpm/tube) was not significantly different from
the expected sum of PHI 12-HETE produced during separate
incubations of macrophages and glomeruli (28,096 5,659
cpmltube). To determine whether the increase in PG production
observed during combined incubation was due to stimulation of
macrophages or of glomeruli, we took advantage of the irrevers-
ible inhibition of cyclooxygenase after aspirin pretreatment. We
compared productions of I3HI PGs from I3HI C20:4 by macro-
phages incubated with aspirin-pretreated glomeruli, by
glomeruli plus aspirin-pretreated macrophages, by untreated
glomeruli plus untreated macrophages and by macrophages
alone (Figure 6). The incubation of macrophages plus aspirin-
pretreated glomeruli resulted in the production of more 13H1PGs
than observed with macrophages alone but produced equal
amounts of PHI PGs as macrophages plus untreated glomeruli
(Fig. 6). Conversely, PG production by glomeruli plus aspirin-
treated macrophages remained negligible. These results dem-
onstrate that macrophages represent the source of PHI PG
production during combined incubation with glomeruli.
Effect of a lipid extract from glomeruli and of 12-HPETE on
the conversion of 13H1 C20:4 by macrophages to PGs and
HETEs. After a 30-mm incubation of glomeruli at 37°C, a lipid
extract was prepared and fractionated on a silicic acid column
to contain lipoxygenase products, mostly 12-HETE and PGs,
but not C20:4. The addition of this lipid extract from glomeruli
resulted in a striking stimulation of the conversion of I3HIC20:4
by macrophages via both the cyclooxygenase and lipoxygenase
pathways. As shown in Figure 7, activation depended on the
amount of glomerular lipid extract added to the macrophages.
The addition of the lipid extract obtained after incubation of
either boiled glomeruli or non-incubated glomeruli (zero time)
did not produce any stimulatory effect but, on the contrary, an
inhibition of synthesis of cyclooxygenase and lipoxygenase
products (results not shown). These results indicate that the
stimulatory factor is produced via an active metabolic pathway
in glomeruli. Exposure of macrophages to 10 n 12-HPETE
during 30 mm at 37°C also produced stimulation of the macro-
phage functions as estimated by the conversion of PHI C20:4
into I3HI 6 keto-PGF1. Nine different preparations of macro-
phages were used. Synthesis of PHI6 keto-PGF1a was 11,715
2,739 and 7,351 2,057 cpm with and without 12-HPETE,
respectively (P < 0.01).
Effect of incubation of macrophages with glomeruli or their
lipid extract on radioimmunoassayable PGs. These experi-
ments were performed to determine in a quantitative manner
the production of PGs from endogenous C20:4 by glomeruli and
macrophages incubated separately or in combination and by
macrophages incubated with the glomerular lipid extract. The
results for 6 keto-PGF1, TXB2, and PGD2 (expressed as
ng/tube) are shown in Table 1. The experimental values ob-
tained during incubations of macrophages and glomeruli com-
bined are compared with the predicted values that represent the
sum of the PG production by macrophages and glomeruli during
separate incubations. Parallel comparisons were performed for
macrophages incubated with the glomerular lipid extract. In
every case, macrophages and glomeruli incubated in combina-
tion produced significantly more PGs than the sum of the values
obtained during separate incubations. When NDGA-pretreated
glomeruli were incubated with macrophages, a marked de-
crease in TXB2 production by macrophages was observed. This
inhibition of TXB2 synthesis depended on the concentration of
NDGA used during preincubation of the glomeruli. Macro-
phages incubated singly and macrophages incubated with un-
treated glomeruli synthesized 9.8 and 20.6 ng/ml TXB2, respec-
tively. After glomeruli were exposed to NDGA, production of
TXB2 by macrophages was 12.6 and 8.3 nglml for 10 and 100 M
NDGA, respectively. In these experiments, we chose TXB2 as
an index of macrophage stimulation. Similarly, the production
of PGs by macrophages was greater in the presence of glomeru-
lar extract than the sum of the PGs contained in the glomerular
extract plus those produced by macrophages incubated alone.
Discussion
The present results show that rat peritoneal macrophages
adhere to glomeruli isolated from rat kidneys. By electron
microscopy studies, the attachment seems to occur predomi-
nantly to denuded glomerular basement membrane (Fig. 1). It is
possible that these areas expose glomerular fibronectin which is
covered normally by epithelial cells. Dubois et al [29] recently
showed that macrophages can adhere to cultured glomerular
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Fig. 5. Synthesis of VH 6 keto-PGFj,, 3H1
TXB2 and 3H PGD2 by glomeruli and macro-
phages incubated alone (G, M) or in combina-
tion (G + M) at 37°C for 30 mm in the presence
of 50 nM 3H arachidonic acid. 3H products
were separated by HPLC. The results of six
individual experiments are given as open sym-
bols; the mean values are shown by closed
symbols. Data corresponding to the same ex-
periments are joined by dotted lines. For the 3
PGs studied, the experimental values (G + M)
were significantly different from the predicted
values for G-alone plus M-alone (P < 0.05).
Fig. 6. Radiochromatograms after high per-
formance liquid chromatography of PGs pro-
duced from 3H 20.4 by macrophages plus
ospirin-pretreated glomeruli (A), aspirin-pre-
treated macrophages plus glomeruli (B), mac-
rophages alone (C), and macrophages plus
glomeruli (D). The retention times of the dif-
ferent standards are indicated by arrows. When
pretreated, macrophages or glomeruli were in-
cubated for 20 mm at room temperature in the
presence of I m aspirin followed by washing.
Experimental incubations with the different
preparations were then carried out for 30 mm at
37CC in the presence of 50 nM I3H C20:4.
mesangial cells and that this may depend on mesangial fibro-
nectin. The binding of macrophages to the glomeruli is an active
process influenced by lipoxygenase products of glomerular
origin (Fig. 3B). This is of particular interest as lipoxygenase
products are known to have chemotactic-kinetic properties
[17]. The binding of macrophages to the glomeruli in our model
occurs in the absence of complement. Thus, lipoxygenase
products may be important in complement-independent ac-
cumulation of macrophages in the mesangial region and in
Bowman's space, as observed in several models of glomerulo-
nephritis. Our model does, however, only allow the study of
macrophage adhesion to the epithelial side of the glomerulus.
Nevertheless, it can be speculated that similar events may
occur with intracapillary macrophage accumulation. A recent
report that synthesis of lipoxygenase products is increased in
glomeruli isolated from rats with nephrotoxic serum nephritis
[30] raises the interesting possibility that this may be a factor
influencing macrophage accumulation at the glomerular site.
The marked diminution of macrophage binding to glomeruli
pretreated with NDGA or with two other inhibitors of the
lipoxygenase pathway, ETYA and phenidone, suggests that
lipoxygenase products synthesized by the glomeruli play a
major role in the binding process. In contrast, the cyclo-
oxygenase products from the glomeruli have no effect because
macrophage binding to glomeruli pretreated by indomethacin
was unchanged. Thus, our experiments suggest that lipoxy-
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Fig. 7. Effect of increasing amounts of glomeru-
tar lipid extract on synthesis of 3H 6 keto-
PGF1, 3H TXB2 and 3H 12- + 15-HETE by
macrophages. Extract (100 pi) corresponded to
300 g of glomerular protein. Macrophages
were incubated for 30 mm at 37°C in the pres-
ence of 50 flM 3H arachidonic acid. Products
were purified by HPLC. The synthesis of 12-
and 15-HETE was estimated together. Results
represent means SEM of three experiments.
6-keto-PGF1 TXB2 PGD2
Experimental Predicted E Experimental Predicted E Experimental Predicted E
value (E) value (P) P value (E) value (P) P value (E) value (P) P
Macrophages plus
glomeruli 32.9 12.3 23.2 10.2 1.42 12.1 2.9 7.0 1.6 1.73 14.9 4.6 4.0 0.9 3.73
Macrophages plus
glomerular extract 40.9 8.3 20.5 9.1 2.00 14.5 3.4 11.3 5.8 1.28 — — —
° Results (ng/tube) are expressed as mean SEM of six individual experiments. PG were measured by radioimmunoassay in the incubation
medium of macrophages and glomeruli alone and in combination. Parallel studies were performed with macrophages and glomerular extract.
Macrophages and glomeruli or glomerular extract incubated in combination came from the same preparations as those used for separate
incubations. The experimental value indicates the means SEM of the actual determination by RIA, while the predicted value represents the sum
of the results obtained from separate incubations of macrophages and glomeruli. The variance of the predicted value was calculated as the sum
of the variances of its two components. The significance of the differences between the experimental and the predicted values were evaluated using
Student's t test for paired values. A significant difference (P < 0.05) was observed in every case.
genase products of glomerular origin influence macrophage
adherence.
To analyze the potential interaction between glomeruli and
macrophages in the conversion of C20:4, we studied the syn-
thesis of PGs and HETEs by glomeruli and macrophages
incubated separately and combined. The results observed dur-
ing separate incubations were similar to those previously pub-
lished as well for macrophages [31, 321 and for glomeruli
[14—161. During combined incubations, glomeruli and macro-
phages synthesized more PGs than the sum of their separate
productions. Identical results were obtained using two different
experimental protocols, radiometric HPLC and direct radio-
immunoassay of PGs under basal conditions. Thus, during
combined incubations, there is a stimulation of PG production
both from exogenous 3H C20:4 and endogenous unlabeled
C20:4. No stimulation was observed for labeled HETE produc-
tion. However, measurement of the total production of HETEs
by coincubation of glomeruli and macrophages does not allow
estimation of the individual productions of HETE by glomeruli
and macrophages. It is thus possible that the unchanged sum
resulted from an increase of the production by one of the two
tissue components and from a decrease by the other. Since the
glomerular lipid extract stimulated synthesis of 12- and 15-
HETE by the macronhaes (Fin. 7). it is likely that durine
combined incubation of glomeruli and macrophages there was
both an increase in HETE production by macrophages and a
decrease in HETE production by glomeruli. The latter effect
was reported in a previous study [311.
The macrophages can be considered as the source of the
enhanced PG produced during coincubation with glomeruli on
the following grounds: (1) Conversion of C20:4 via the cyclo-
oxygenase pathway is minor compared with that via the
lipoxygenase pathway in rat glomeruli whereas both pathways
play an equal role in macrophages (Fig. 4). (2) The profile of PG
synthesis by coincubated macrophages and glomeruli was
closer to that by macrophages incubated alone than to that by
glomeruli incubated alone. In particular, 6 keto-PGF1a produc-
tion was predominant whereas the peak x1 corresponding to an
unidentified cyclooxygenase product synthesized by the
glomeruli was absent. (3) A glomerular lipid extract devoid of
arachidonic acid markedly stimulated 6 keto-PGF1 and TXB2
production by macrophages. (4) Production of PGs by aspirin-
pretreated (that is, cyclooxygenase inhibited) macrophages and
control glomeruli incubated in combination was very low,
whereas production of PGs by control macrophages and aspirin-
pretreated glomeruli incubated in combination was similar to
that observed with control macrophages plus control glomeruli.
It is hence reasonable to conclude that durine coincuhation of
6 keto-PGF1,,
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macrophages and glomeruli, macrophages are stimulated and
produce increasing amounts of PGs.
Since a glomerular lipoxygenase product influences the at-
tachment process of macrophages to glomeruli, we investigated
the possibility that such a product was also responsible for the
stimulation of the PG synthesis by the macrophages. The
glomerular lipid extract containing oxygenated metabolites of
C20:4 was a potent stimulator of PG and HETE synthesis by the
macrophages. Stimulation cannot be attributed to C20:4 since
this fatty acid was excluded from the extract by chromatogra-
phy purification. The role of a lipoxygenase product is sug-
gested strongly by the fact that the stimulation of macrophages
was not decreased by pretreatment of glomeruli with a cyclo-
oxygenase inhibitor. Since 12-HETE is the main product of the
lipoxygenase pathway synthesized by the glomeruli [14, 15], we
thought that its active and unstable precursor, 12-HPETE,
would be a good candidate as the factor responsible for the
stimulation of macrophage functions. At 10 flM, this metabolite
enhanced by approximately 60% the conversion of 3H C20:4
into 3HJ 6 keto-PGF1 in the macrophages whereas 12-HETE
itself was inactive. This concentration is in the range of what is
produced under basal conditions by isolated glomeruli in vitro
[14], suggesting that glomeruli can stimulate macrophage func-
tions without prior attachment.
The mechanism of the stimulation by a glomerular
lipoxygenase product of PG production by macrophages re-
mains to be elucidated. Since there was an increase in the
production of both the cyclooxygenase and the lipoxygenase
products, it is likely that stimulation occurred at the stage of
C20:4 availability. The availability of C20:4 for conversion by
either cyclooxygenase or lipoxygenase does not only depend on
deacylation but also on the rate of reacylation. Under condi-
tions we arranged, the degree of stimulation of PG synthesis
from exogenous 3H C20:4 was greater than that from endog-
enous unlabeled C20:4 as determined by RIA. This could be
interpreted as indicating an inhibition by the glomerular factor
of the process of reacylation of I3H C20:4 into the membrane
phospholipids. However, to elucidate the exact mechanism,
future studies with prelabeled cells will be required. The fact
that an unstable HPETE is responsible at least in part for
macrophage stimulation is noteworthy. It has been shown
similarly, that 12-HPETE from platelets stimulated the synthe-
sis of lipoxygenase products in leukocytes [28]. Based on the
present results, we would like to propose the following hypoth-
esis: Lipoxygenase products of glomerular origin can influence
adhesion of monocyte-macrophages to the glomerulus. At the
same time, the lipoxygenase products can stimulate PG synthe-
sis by macrophages. Such a correlatjon between adhesion of
niacrophages and production by these cells of TXB2 and 6
keto-PGF1c. also has been observed by Koyama et al [33]. This
increased production of PGs may, in turn, inhibit the synthesis
of l2-HPETE by glomeruli and thus limit adherence of macro-
phages.
An imbalance between the synthesis by glomeruli of
lipoxygenase products and the synthesis by macrophages of
PGs could either favor or prevent macrophage adhesion and
proliferation. Enhanced glomerular lipoxygenase activity as
may occur in experimental glomerulonephritis [30] could thus
represent a complement-independent factor for macrophage
accumulation in glomeruli. On the other hand, exogenous PGE1
administration decreases glomerular immune injury [34] which
could possibly be via inhibition of macrophage adhesion, cell
proliferation [35], and the ensuing glomerular damage.
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